Back

The role of fluorodeoxyglucose-positron emission tomography imaging in suspected inflammatory cardiomyopathy

17 May 2025 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Multimodal imaging in cardiac amyloidosis and cardiomyopathies Imaging HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Valentina Alice Rossi

University Hospital Zurich, Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
Prognostic value of right ventricular longitudinal strain in patients with transthyretin amyloid cardiomyopathy
Doctor E. Tan (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Prognostic role of myocardial strain and its relationship with diffuse myocardial fibrosis accentuated by diabetes mellitus
Doctor S. Chadalavada (Ashford, GB)
Abstract Slides Video
Presentation thumbnail
Left atrial strain has prognostic value in dilated cardiomyopathy patients with recovered ejection fraction
Mr M. Venner (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodal imaging in cardiac amyloidosis and cardiomyopathies

The Event

Event poster

Heart Failure 2025

17 May 2025 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Role of PET-CT in inflammatory cardiomyopathies.
22 May 2022
thumbnail
Congress Presentation
Prognostic implications of residual cardiac FDG uptake in stable cardiac sarcoidosis post-immunosuppressive therapy
1 September 2025
thumbnail
Congress Presentation
Increased cardiac and splenic 18F-FDG activity in patients with peripartum cardiomyopathy.
13 May 2024
thumbnail
Congress Session
Molecular imaging of the heart: the added value of PET
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources